Brussels, 11 December 2018

ELPA Stakeholders’ Meeting is held annually and is created to serve as a means of exchanging ideas and proposals, as well as to help sinchronise policy activities of relevant liver disease stakeholders. This year's Stakeholders' meeting was held on 26 November back to back to our EGM and Advisory Board meetings in Ljubljana. Attended by ELPA members and our partners in the field, we have used the opportunity to present our highlights in 2018, as well as the plans for 2019.

Although HCC is the sixth most commonly-diagnosed cancer globally, and the second-leading cause of cancer deaths annually, there are very few organisations that focus on HCC patients. As a result, HCC patients may not be receiving adequate support and information about their condition.